The genome sequence of Plasmodium falciparum reveals that many metabolic pathways are unique as compared to its human host. Metabolic Network Analysis was carried out to¯nd the essential enzymes critical for the survival of the pathogen. In the present study, choke point and load point analysis was used to locate putative targets. The identi¯ed targets were further checked to con¯rm that no alternate pathway or human homolog exists. Among the top 15 enzymes obtained from this analysis, we have selected P. falciparum orotidine-5'-monophosphate decarboxylase (PfODCase) enzyme as it is sequentially and structurally di®erent from that of humans, for searching novel inhibitors. A¯ve-point 3D pharmacophore was generated for the crystal structure of PfODCase complexes with uridine-5'-monophosphate (U5P). The binding site environment shows three H-bond acceptors, one H-bond donor and one negative ionizable feature. This pharmacophore model was used as a 3D query to perform virtual screening experiments against 2,664,779 standard lead compounds obtained from the freely available ZINC database. Top 10 hits obtained from virtual screening were selected for molecular docking experiments against PfODCase in order to verify their results and to have a better insight into their binding modes. Here, docking of U5P with PfODCase is used as a control. We have identi¯ed six compounds, among them, few are U5P analogs and others are novel ones with diverse sca®olds. The key residues: Lys42, Asp20, Lys72, Ser127, Ala184, Gln185 and Arg203 at the main binding pocket of PfODCase are responsible for better stability of diverse ligands. These compounds according to their free energy of binding could serve as potent leads for designing novel inhibitors against malarial ODCase enzyme.
Introduction
Malaria is one of the most common infectious disease and an enormous health problem. It is solely responsible for nearly three million deaths and close to¯ve billion episodes of clinical illness each year throughout the world, with Africa bearing more than 90% of the burden.
1,2 A number of Plasmodium species causes malaria, of which Plasmodium falciparum is the deadliest. 3 This most virulent form causes malaria by invading both the reticulocytes and the mature red blood cells. 4 With the decoding of the complete genome of P. falciparum, one can study this organism on the whole genome basis. 5, 6 PlasmoDB (http://plasmodb.org/) is the o±cial website for studying the P. falciparum 3D7 genome and proteome, and its curation is handled by the members of genome consortium group.
Sustained research spanning several decades has been done to eradicate malaria but the scienti¯c community has experienced little success. One of the main reasons behind this low success rate is their rapidly evolving genetic structure. Many drugs were invented to combat this disease, but the majority failed due to development of resistance against antimalarial drugs. Till date, no e®ective vaccines are available for malaria, and also the available drugs in the market usually become less e®ective due to high rate of antigenic variations.
7À9
Computational study of comparative metabolomics of pathogens provides a new tool for the identi¯cation of potential drug targets. In order to study the drug targets, their cellular mechanism and interactions between cellular components are increasingly becoming more important for assessing their inherent properties in biochemical reaction networks. Metabolic pathways exemplify how one protein works in concern with another one for transmitting information at cellular and other levels. Drug target identi¯cation based on \omics" is a very promising approach in the present scenario.
A metabolic network consists of reactions, metabolites and enzymes. The graphtheoryÀbased pathway analysis is an important tool to increase our understanding of metabolic networks. Metabolite-centric graph, having a large number of connecting links, represents metabolites as nodes and reactions as edges. This type of network representation allows the characterization of metabolic pathways on the basis of degree of metabolites. The degree of metabolite is de¯ned as the possible number of reactions undergone by that particular metabolite, and its degree of interconnectivity is de¯ned by the average shortest path.
10À13
In this study, we have used metabolic network analysis of P. falciparum using its load point and choke point features. The homology search was performed taking identi¯ed choke point enzymes against the human database. Unique enzymes were identi¯ed and further used in computer-aided drug designing. In the current research, 3D pharmacophore modeling approach was used to construct descriptors involved in proteinÀligand complex interaction. Structure-based virtual screening (SBVS) was used to¯nd the unique hits with desired inhibition activity in the drug designing process. These hits were further re-examined by molecular docking against PfODCase, and their physico-chemical properties were also calculated for establishing them as potent drug prototypes. We have successfully identi¯ed hit compounds that have desired inhibition activity.
Methodology
The necessary step for understanding the metabolic network of P. falciparum is to extract annotated protein information along with its metabolic network information. This study is based on load point and choke point for predicting possible drug targets. This analysis was carried out using the Pathway Hunter Tool (PHT) to identify enzymes that are vital for proper functioning of pathogen networks. 14 In a metabolic network, load point of a metabolite is the ratio of the number of k-shortest paths passing through them and their nearest neighbor links. 15 Enzymes having high load value depict their higher connectivity of shortest paths passing through nodes and lesser nearest neighbor links. The importance of an enzyme is directly proportional to the number of connections and vice versa. 16 Therefore, enzymes having a high number of connections are central to the metabolism and play a crucial role. The disruption of these enzymes will limit the survival of the organism. Choke point analysis was used here for identifying unique drug targets. 17 Basically, choke point reactions are those that either uniquely consume a speci¯c substrate or produce a speci¯c product in the pathway. It can be anticipated that inhibition of such enzymes that produce choke point substrates results in their accumulation, which is toxic to cell, and on the other hand, inhibition of enzymes that produce a unique product will lead to starvation of this product and the domino e®ect in cessation of important cell functions. 17 
Identi¯cation of potential drug targets
The complete genome sequences of pathogen P. falciparum and Homo sapiens were taken from the NCBI site (www.ncbi.nlm.nih.in). Metabolic pathway information required for analyzing functional status of genes and their genomes were taken from the KEGG database. 18 The information residing in metabolic network is extracted by calculating the average path length, shortest path distribution and alternate shortest paths using PHT software.
14 The shortest path distribution between two interacting metabolites in a metabolic network is calculated by using their structural-similarity criteria. This involves calculation of local and global structural similarity score. The local and global similarity score quantify the amount of structural similarities among interacting intermediate metabolites, and sourceÀdestination metabolites after considering a series of reaction steps. The higher these similarities, the smaller will be the average degree of nodes. In this study, local similarity (15%) and global similarity (5%) scores are set to software's default value. We have identi¯ed choke point enzymes in P. falciparum and ranked them according to number of incoming/outgoing shortest paths along with their load point values, and eventually, the top 15 choke point enzymes were further analyzed.
A network-based comparative study of these important choke point enzymes were performed against human metabolic enzymes in order to di®erentiate between them. An additional criterion of homology search was used to reduce our genome search space for identifying appropriate drug targets. Lack of similarity against the human enzyme is a prerequisite for a good target. So, top choke point enzymes obtained from metabolic network analysis were subjected to a BLASTp search program 19 against nonredundant human protein database using expected value less than 0.001.
ProteinÀligand complex preparation
The crystal structure of P. falciparumPfODCase complexes with U5P of resolution 1.6 Å was taken from Brookhaven protein data bank (PDB ID: 2E6Y).
20À22 It is a homo-dimer consisting of chains A and B. We have removed chain B and water molecules from the complex, and the remaining complex was energy-minimized in order to remove strain as well as steric clashes from protein backbone and amino acid side-chains, respectively, using MMFF94 force¯eld of LigandScout package. 23, 24 2.3. Structure-based pharmacophore modeling and virtual screening
The structure-based 3D pharmacophore model of re¯ned PfODCase-U5P complex is generated using LigandScout's algorithm, which calculates and displays chemical interactions between proteinÀligand complexes. These chemical features are used for 3D-pharmacophore generation. The hydrogen bond donors and acceptors are represented by directed vectors and charge-transfer interactions and lipophilic regions by spheres. LigandScout provides a strong graphical user interface of molecule, pharmacophore models and interaction lines, helping in the visualization and interpretation of the proteinÀligand complex. The pharmacophore model uses spatial information by considering the steric hindrance of the complex. The selectivity of the automated generated pharmacophore model is further increased by placing exclusion volume spheres at the coordinates of the lipophilic centre. The LigandScout and Catalyst algorithm 24, 25 are used for 3D-Pharmacophore model generation by the detection and stepwise interpretation of proteinÀligand interactions for rapid virtual screening of our in-house ligand database.
A local database of 2,664,779 compounds was created using standard lead compounds of ZINC database (a public accessible database of commercially available compounds). 26 The pharmacophore model derived from PfODCase-U5P complex was used here for screening our local database, and the natural ligand U5P was also used as a control to cross-check screening results.
Docking
The individual molecular docking experiments were performed by using ADT GUI of Autodock v4.2 27 in order to better understand and to have deep insight into interactions between identi¯ed hits and protein active-site residues. In the process of ligand preparation, Gasteiger charges were added and maximum possible torsions were allowed. Macromolecule centered 3D-grid of dimensions 126 Â 126 Â 126 was prepared with 0.375 spacing for each atom type. Lamarckian genetic algorithm was selected in autodock for conformational search as it is e®ective for molecules having up to 10 rotatable bonds. Common docking parameters: 40À120 GA runs, population size of 150, maximum energy evaluations in the range of 250,000, maximum number of generations 27,000, mutation rate 0.02, cross-over rate 0.8 and other parameters were set to software's default value. PyMOL 28 was used for visualization of docking results.
The topological polar surface area (TPSA), lipophilicity and ability to cross the blood-brain barrier were calculated for our preferred identi¯ed hits using Preadmet server (http://preadmet.bmdrc.org/).
Results and Discussion

Metabolic network analysis of P. falciparum based on choke point theories
In silico comparative study of metabolic network pathways of the host H. sapiens and the pathogen P. falciparum has been performed by ranking metabolites on the basis of their load point and choke point properties. The metabolic network of P. falciparum contains critical information regarding their physiological and biochemical properties. As we know, nodes (metabolites) and edges (reactions) are main basis for choke-pointÀbased network analysis, so metabolic networks have been studied with the focus on choke points. The degree of nodes is an important characteristic of networks, which tells us about the number of connections or edges by which one node connects with others. This information was used to calculate the shortest paths between metabolites, and these shortest paths were also found more suitable in respect of minimum energy function. The average path length is the mean over shortest paths between all pair of nodes in the entire network. The average path length and average degree of entire network were also calculated for in-depth study of network topology. 13 The metabolic network of P. falciparum was studied using Pathway Hunter Tool (PHT). The important properties of network are shown in Table 1 . This metabolic network study involves 243 enzymes, 465 reactions and 605 metabolites, with an average path length of 7.21. In this network, the number of enzyme reactions is more compared to the enzymes because many enzymes catalyze more than one reaction. On the basis of global and local structural similarities between node points, the average degree is found to be 2.74. In this metabolic network, each source metabolite is connected to its destination metabolite with multiple paths of varying length. The path length represents the number of connections required to traverse from one node to other accessible nodes. Many alternate paths also exist between each pair of nodes. Among all the connections that may occur between the source and destination, connections having shortest path are preferred most of the time in order to conserve energy. The shortest path distribution in the studied network is shown in Fig. 1(a) . Here, the x-axis represents path length while y-axis shows relative frequencies of metabolites. Figure 1(a) clearly shows that the frequency of metabolites are maximum at path length 3 and comparatively higher for path length 8, 9, 10 and later on it gradually decreases. So we can interpret that relative frequencies of metabolites following optimal path lengths are high in this case. The basic architecture of metabolic network shows higher connectivity of some metabolites in comparison to others. These metabolites sitting in middle of the busiest routes are considered essential for pathogen's survival. Removal of these hubs from the network should disable it. But this does not always happen because network tra±c rescue from this situation due to availability of some compensating alternate paths. 13 Thus, before blocking some important hubs, one has to detect alternate paths because these are mainly responsible for pathogen's survival under extreme situations. Alternate shortest path distribution in P. falciparum pathogen is shown in Fig. 1(b) . From the shortest path and alternate path distribution, it can be anticipated that metabolites following the minimum reaction step during their interconversion and having minimum alternate paths are essential for network stability. Targeting these hubs will probably block the tra±c passing through them.
Analysis of top 15 choke point enzymes in P. falciparum
The top 15 choke point enzymes in P. falciparum were identi¯ed and their ranking was done by calculating number of shortest paths, using Pathway Hunter Tool (Table 2 ). Since this network is a directed one, both in°ux and e®lux were calculated. Enzymes having high load value and high number of shortest path length are considered important in cellular metabolism. So, the identi¯ed choke point enzymes were ranked according to their shortest path availability. By applying this strategy, we have identi¯ed choke point enzymes having high probability of lethality to the pathogen. Here, only those choke point enzymes were selected that did not have isozymes, or in other words, not having isozymes was a precondition to qualify as a potential drug target. Comparative analysis of pathogen's choke points and their similarity with human choke points was considered for searching unique drug targets. BLASTp algorithm was used with an expected threshold of 0.001 for searching human homologs. The identi¯ed enzymes in this study play a critical role in various biochemical pathways, and this can also be veri¯ed from \Malaria parasite metabolic pathways" database (http://priweb.cc.huji.ac.il/malaria/).
Among the top 15 choke point enzymes identi¯ed, 3 enzymes show no human homologs. These enzymes are 6-phosphofructokinase (EC 2.7.1.11), orotidine 5'-phosphate decarboxylase (EC 4.1.1.23) and acetate-CoA ligase (EC 6.2.1.1). The three enzymes identi¯ed through the metabolic network analysis of P. falciparum are well-established drug targets.
29À31 So targeting these enzymes will most probably interrupt the metabolic°ow of critical metabolites in the pathogen. The ODCase enzyme of P. falciparum is sequentially and structurally di®erent from its human counterpart and also plays a central role in de novo synthesis of U5P, which leads to the synthesis of other pyrimidine nucleotides À À À UTP, TTP and CTP. While in humans, there is an additional route named salvage pathway along with the de novo pathway for pyrimidine synthesis. 32, 33 Thus inhibition of malarial ODCase activity will only a®ect pyrimidine biosynthesis in Plasmodium, not in humans, which makes it a promising drug target against malaria. 
Structure-based pharmacophore model of PfODCase complex
The energy of chain A of PfODCase-U5P complex is minimized in order to remove strain from it. A¯ve-point feature-based structural pharmacophore was built on the basis of key interactions involved. The U5P ligand lies at the protein active-site and interactions between them, along with exclusion spheres are shown in Fig. 2 . Here, the binding site environment shows three hydrogen bond acceptors, one hydrogen bond donor and one negative ionizable feature. The negative ionizable feature consists of phosphate group and is represented by a sphere of tolerance radius 1.5 Å, and it interacts with the opposite ionizable feature of Arg203 located on the macromolecule side within the distance of 1.5À5.6 Å. The binding pocket shows strong hydrogen bond network involving Lys42, Asp70, Ser127 and Gln185 residues. The selectivity of this pharmacophore model is further increased by involving 11 exclusion volume spheres.
Structure-based virtual screening
The 3D pharmacophore model of PfODCase-U5P complex is used for SBVS of our in-house database. Docked conformations of ligands were evaluated and ranked by considering all chemical features of pharmacophore model using catalyst algorithm. Finally, 29 hits were obtained from SBVS and ranked according to their pharmacophore¯t scores as shown in Table 3 . The visual inspection and further analysis of these hits are done using LigandScout GUI. All identi¯ed hits contain an aromatic ring except ZINC17060939 (hit 16). The calculated molecular weight of these hits varies from 234 to 346.22, with an average of 298.49, thus nearly all values are ful¯lling the criteria of drug compounds. 
Docking
Among identi¯ed hits, the top 10 hits were selected on the basis of pharmacophore¯t values. These hits were further analyzed by docking experiments using stringent parameters. Autodock tool is used to evaluate hit compounds on the basis of their H-bond interactions and binding energy with the complex.
The identi¯ed hits were subjected to blind docking experiments taking whole protein available for binding. In order to check whether the docking and scoring procedure used here is able to¯nd the correct binding site, we have performed a cross-check validation experiment, taking U5P as a ligand and PfODCase protein as a receptor. The result shows that the docked structure of U5P-PfODCase complex is in accordance with their crystallographic structure with an rmsd value of 2.2 Å. In the docked complex, our in-house ligand U5P also binds to same active-site and its uridine moiety and phosphate group are involved in making hydrogen bonds with Lys42, Lys72, Ala184, Gln185 and Arg203 residues (Fig. 3) . The binding free energy associated with the complex is À8.17 Kcal/mol with an inhibition constant of 1.02 M. The same docking and scoring parameters are used for docking analysis of other hit compounds. SBVS was performed using the¯ve-point pharmacophore features/search, based upon the chemical features extracted from the main binding site of U5P-PfODCase complex. Being the site-speci¯c search, SBVS provided us the hit compounds that are able to bind at main active-site. There is equal probability of binding to some other additional binding sites, when these hit compounds were docked against the whole protein. So, hit compounds, including U5P, bind to PfODCase at the primary binding site as well as to some other binding sites within a distance of 12À24 Å.
The docked complexes of hit compounds 2, 3, 6, 7, 8 and 9 bind with active-site residues of primary binding site (Fig. 4) . The possibilities of binding of these hits to some other binding sites are also detected, but their minimum energy cluster shows high binding a±nity for the main active-site and number of conformers belonging to this lowest energy cluster is also very high (Table 4) .
Cluster one of hit-2 contains three conformers that lies at primary binding site and shows 5À8 hydrogen bond interactions. The lowest energy conformer (À7.33 Kcal) forms a hydrogen bond with Asp70, Ala184, Val182, Gly202, Arg203, Ser204 and Tyr206 amino acid residues. The side-chain oxygen of Asp70 involves in hydrogen bonding with amino group attached to the purine ring of ligand. NH hydrogen atoms of the main chain Ala184, Gly202, Arg203, Ser204 and Val182 make a network of hydrogen bonds with the phosphate group of ligand, and oxygen of side chain aromatic ring of Tyr206 interacts with hydroxyl group of pentose ring of ligand. A pi-cation interaction occurs between purine ring of ligand and side-chain NH of Lys42 (Fig. 4(a) ). The lowest energy cluster of hit-3 has two conformers which bind to the primary pocket and shows two interactions. Lowest energy conformer (À7.33 Kcal) is involved in the interactions with Asp20 and Ser127. The hydroxyl group at 2'C of ribose ring and phosphate group of ligand interact with the side-chain carboxylate of Asp20 and side-chain oxygen of Ser127 respectively (Fig. 4(b) ).
In case of hit-6, the lowest energy cluster has three conformers and its minimum energy conformer (À6.67 Kcal) shows hydrogen bonding with Lys42, Lys72, Gln185 and Arg203 residues. Side-chain NH hydrogen atom of Lys42 and Lys72 interacts with the hydroxyl group of pyran ring and carboxylic group of benzene ring of ligand respectively. Carboxylic side-chain of the pyran ring makes three hydrogen bonds with Arg203 and one with Gln185 (Fig. 4(c) ).
The lowest energy cluster of hit-7 complexes with PfODCase contains¯ve conformers, and its minimum energy conformer (À7.82 Kcal) is involved in hydrogen bonding with the Val182, Ala184, Arg203, Ser204 and Asp20. Two out of three side-chain hydroxyl groups of the pyran ring are interacting with Val182 and Asp20. Pyran ring oxygen atom makes two hydrogen bonds with Arg203, while side-chain carboxylic group of pyran ring is interacting with Ser204 and Ala184 (Fig. 4(d) ).
The docked complex of hit-8 contains single conformer in the lowest energy cluster (À7.7 Kcal) and engages in hydrogen bonding with Val182, Asp20, Lys72, Ala184, Arg203 and Ser204 residues. The side-chain hydroxyl group and nitrogen of pyridine ring interact with Val182, Ala184, Ser204 and Arg203 with a network of hydrogen bonds. The carboxylic side-chain and main chain NH of ligand interact with the NH hydrogen of Lys72 and side-chain carboxylic group of Asp20 through hydrogen bonds, respectively (Fig. 4(e) ).
The docking of hit-9 at main active-site shows three conformers in the lowest energy cluster (À7.12 Kcal) which involves in hydrogen bond interactions with Ser127, Val182, Arg203, Asp20, Lys42, Lys72 and Gln185 residues. The side-chain hydroxyl group of Ser127 forms a hydrogen bond with the amino group hydrogen of ligand. Carboxylic oxygen of Val182, NH2 of Arg203, HN and HE21 of Gln185 form a hydrogen bond network with the phosphate group of ligand. The hydroxyl group of furan ring and nitrogen of triazole ring are involved in hydrogen bonding with HZ1 of Lys42 and HZ1 of Lys72, respectively (Fig. 4(f) ).
The conformers of hit-1, 4, 5 and 10 are docked at both: the main binding site as well as some additional binding sites of PfODCase enzyme (Figs. S1 and S2 of Electronic Supplementary Material). But their minimum-energy conformer binds to additional sites more¯rmly than its main binding pocket. The presence of these additional binding sites may increase the possibility of allosteric inhibition of PfODCase activity or, on the other hand, decrease the chance of binding of ligands to the main binding site and hence, increases the chance of blocking desired pathway.
The molecular docking of the PfODCase with identi¯ed hits reveals that Lys42, Lys72, Asp20, Ala184, Gln185, Arg203 and Ser127 are key residues involved in forming a hydrogen bonding network and contributes to the stability of ligands at the main binding pocket. Along with the hydrogen bond interactions, Lys42 and Lys72 residues are also involved in pi-cation interaction with aromatic ring of ligands, so these residues might be crucial for selectivity and stability of PfODCaseligand complex. It is noteworthy that, among the identi¯ed top 10 hits, hit-2 and 3 are close analogs of U5P, a natural ligand of PfODCase, thus these hits compete with U5P for the same binding site. The other hit compounds constitute novel chemotypes of PfODCase inhibitors.
Physico-chemical property studies
Although all the top 10 hits bind at the main active-site of PfODCase, the minimumenergy conformers of hit-2, 3, 6, 7, 8 and 9 show higher a±nity at this site. So, six of these hits were further analyzed according to its physico-chemical properties: TPSA, XlogP and ability to cross the blood-brain barrier. TPSA represents the surface area of all polar atoms (nitrogen, oxygen, sulphur and their attached hydrogen atoms), and it is directly correlated to the passive transport of compounds through membranes. Here, its value ranges from 130À195. The XlogP value provides information on the lipophilicity and is associated with higher permeability and bioavailability of drugs. Here XlogP values for these hits lies between À3.82 and À0.5. The C brain = C blood value represents the ability of a compound to pass across blood-brain barrier and here its range is 0.01À0.81 (Table 5) .
The physico-chemical values of these hits are not lying exactly in the expected optimal range of drug-like compounds but they are quite closer to them. We have also calculated these properties for U5P, a natural ligand of PfODCase enzyme, and its values are quite closer to our identi¯ed hits. The physico-chemical analysis, along with the docking results, shows that these hits possess the desired ADMET properties and have ability to successfully bind at the main active-site of PfODCase enzyme.
Conclusion
In this study, we have successfully applied choke point and load point analysis for searching unique enzymes in the metabolic network of P. falciparum. Among the top 15 choke point enzymes obtained by analyzing the metabolic network, three of them were selected because they have no human homologs. Inhibition of these enzymes will probably block the°ow of certain metabolites in the metabolic network and hence restrict the pathogen's survival. In this study, PfODCase enzyme has been chosen further because it is a crucial enzyme involved in de novo pyrimidine biosynthesis and also di®ers fom their human counterpart. These features make this enzyme a highly promising target to develop antimalarial drugs. The 3D-structureÀbased pharmacophore model has been created for PfODCase-U5P complex, and virtual screening is performed against our in-house database. Molecular docking of selected hits, obtained from virtual screening, is done against PfODCase enzyme, taking U5P ligand as a control. Later on, docking results identi¯ed six novel compounds that bind to the main active-site of PfODCase with comparatively less free energy of binding. Among these, hit-2 and 3 are close analogs of their natural substrate U5P, while other four hits were structurally diverse. The physico-chemical properties of these identi¯ed hits along with U5P are in close agreement with the drug properties. Thus these hits might be proven as better inhibitors that will cease the desired enzymatic activity, ultimately leads in blockage of their respective pathway. Docking studies also reveals information about residues involved in interactions with ligands responsible for holding it in the active-site pocket. This information might be further used to study the role of these residues in selectivity and speci¯city of ligands through mutagenesis and QSAR experiments. Furthermore, the proposed pharmacophore model and the di®erent binding modes of these hits in the binding pocket of PfODCase would provide vital information for searching and designing novel PfODCase targeted drugs. With all the above information and in light of physicochemical properties, these identi¯ed inhibitors should be treated only as drug prototypes for antimalarial drugs.
